Jane Oowo Anyiam

Prof. Jane Oowo Anyiam

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2008 in Nigerian Journal of Medicine
Verified
Journal Article
Closed access
PDF file
JAJane Oowo Anyiam
Jane Oowo Anyiam
WOWn Ogala
Wn Ogala
COCu Onuora
Cu Onuora
Body Mass Index of Healthy Nigerian Children

1 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAmina Yusuf Ali
Amina Yusuf Ali
MYMercy Doose Yough
Mercy Doose Yough
AYAbubakar Yakubu
Abubakar Yakubu
JAJane Oowo Anyiam
Jane Oowo Anyiam
BEBashir Adebayo Elegbele
Bashir Adebayo Elegbele
MBMarycelin Mandu Baba
Marycelin Mandu Baba
Background: This study monitored the viral content of the Novel Oral Polio Vaccine Type 2 (nOPV2) and VVM degradation during storage at different temperatures over a specified period. Method: Weekly vaccine titers were obtained until the vaccine vial monitor (VVM) degraded to 100%, except when stored in a refrigerator. Results: At refrigerator temperature, 90% and 10% of the vaccine vials retained potency for six and seven months, respectively, but none retained potency at 8 to 9 months. The median survival time was approximately seven months. The VVM remained at 0% degradation up to 4 months and changed to 5%, 10%, 20%, 30%, and 40% after 5, 6,7,8 and nine months, respectively. At room temperature, the nOPV2 retained potency during the first two weeks, declined by the third week, and none retained potency by the fourth week. The degradation of the VVM was rated 10 %, 30%, 60%, and 100% after one, two, three, and four weeks of storage, respectively. The median survival time at incubator temperature was one week, during which 10% and 90% of the vaccine in batches 2 and 1, respectively, survived, but all vials reached 0.0% at week 3. At atmospheric temperature, the survival probability was zero within a week of exposure. Time accounted for over 80% of the variation in vaccine titer. Conclusion: The potency of the nOPV2 was preserved under refrigeration for seven months, at room temperature for two weeks, in an incubator for a week, and severely degraded at atmospheric temperatures within a week.